title: The telomerase RNA component Terc is required for the tumour-promoting effects of Tert overexpression.
abstract: A role for the telomerase reverse transcriptase subunit (Tert) in tumorigenesis independent of telomere length is emerging. K5-Tert mice, which overexpress Tert in the skin, show increased tumorigenesis and faster wound healing than wild-type controls. Here, we demonstrate that the telomerase RNA component Terc is necessary to mediate these effects of Tert overexpression. In contrast to K5-Tert mice, K5-Tert mice in a Terc-deficient background, K5-Tert/Terc-/-, do not show increased tumorigenesis or increased wound healing compared with wild-type controls. Indeed, K5-Tert/Terc-/- mice show a reduction in tumour growth compared with Terc-/- controls, indicating an inhibitory effect of Tert overexpression in the absence of Terc. These results indicate that the tumour-promoting effects of Tert overexpression require the formation of Tert-Terc complexes. In addition, we show that the increased expression of Tert in the absence of Terc has an inhibitory effect on tumorigenesis, independently of telomere length and telomerase activity. These findings highlight Terc as a target for telomerase-based anticancer therapies.
authors.affiliation: Molecular Oncology Program, Spanish National Cancer Center (CNIO), 28029 Madrid, Spain.
authors.forename: María Luisa
authors.initials: ML
authors.lastname: Cayuela
authors.forename: Juana M
authors.initials: JM
authors.lastname: Flores
authors.forename: María A
authors.initials: MA
authors.lastname: Blasco
mesh_terms: D000818:Animals; D002471:Cell Transformation, Neoplastic / Q000187:drug effects / Q000235:genetics*; D043171:Chromosomal Instability / Q000235:genetics; D002869:Chromosome Aberrations; D004268:DNA-Binding Proteins; D017353:Gene Deletion; D017404:In Situ Hybridization, Fluorescence; D015603:Keratinocytes / Q000378:metabolism; D051379:Mice; D018345:Mice, Knockout; D009154:Mutation / Q000235:genetics; D009369:Neoplasms / Q000235:genetics* / Q000378:metabolism / Q000473:pathology*; D021122:Protein Subunits / Q000235:genetics / Q000378:metabolism; D012313:RNA / Q000235:genetics / Q000378:metabolism*; D012878:Skin Neoplasms / Q000139:chemically induced / Q000235:genetics / Q000378:metabolism / Q000473:pathology; D019098:Telomerase / Q000235:genetics* / Q000378:metabolism*; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology; D014945:Wound Healing
chemical_list: D004268:DNA-Binding Proteins; D021122:Protein Subunits; C422952:telomerase RNA; D012313:RNA; D019098:Telomerase; C509187:Tert protein, mouse; D013755:Tetradecanoylphorbol Acetate
references.citation: Nat Genet. 2000 Sep;26(1):114-7
references.pmid: 10973262
references.citation: J Cell Biol. 2004 Nov 22;167(4):627-38
references.pmid: 15545322
references.citation: Oncogene. 2002 Jan 21;21(4):584-91
references.pmid: 11850783
references.citation: Proc Natl Acad Sci U S A. 2002 Jun 11;99(12):8191-6
references.pmid: 12034875
references.citation: Nat Rev Cancer. 2002 Aug;2(8):627-33
references.pmid: 12154355
references.citation: Proc Natl Acad Sci U S A. 2002 Oct 1;99(20):12606-11
references.pmid: 12193655
references.citation: Nature. 2003 Feb 6;421(6923):643-8
references.pmid: 12540856
references.citation: Nat Cell Biol. 2003 May;5(5):474-9
references.pmid: 12717449
references.citation: Clin Cancer Res. 2003 Oct 15;9(13):4705-13
references.pmid: 14581340
references.citation: Mol Cell. 2003 Dec;12(6):1511-23
references.pmid: 14690604
references.citation: Mol Cell Biol. 2004 May;24(10):4275-93
references.pmid: 15121848
references.citation: Nature. 1984 Feb 16-22;307(5952):658-60
references.pmid: 6694757
references.citation: Nat Genet. 1996 Feb;12(2):200-4
references.pmid: 8563761
references.citation: Mol Cell Biol. 1996 Jul;16(7):3765-72
references.pmid: 8668193
references.citation: Cell. 1997 Oct 3;91(1):25-34
references.pmid: 9335332
references.citation: Cell. 1999 May 14;97(4):515-25
references.pmid: 10338215
references.citation: Cell. 1999 May 14;97(4):527-38
references.pmid: 10338216
references.citation: EMBO J. 2001 Jun 1;20(11):2619-30
references.pmid: 11387197